Study of the Prostatex Plus effectiveness in patients after transurethral resection for benign prostatic hyperplasia
Introduction. The course of the postoperative period in patients with benign prostatic hyperplasia (BPH) who have undergone transurethral resection (TUR) remains an important issue. Adequate relaxation of the muscle tone of the prostatic urethra and bladder neck is crucial in the postoperative period.
Materials and methods. The article presents the results of the study evaluating the drug Prostatex plus in patients with BPH who underwent transurethral resection of the prostate (TURP).